Many gynecologists and urologists from all over the world are practicing the use of vaginal mesh implants as tool to repair the two conditions known to many adult women: Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP). But this popularity is yet to change after incidences of its negative effects were experienced by many recipients and reported to the U.S. Food and Drug Administration (FDA) recently. In fact, there were thousands of negative cases reported, and this number is expected to climb even higher. Some people might not expect these negative outcomes, but the failure of the vaginal mesh to provide safety to its users can be traced to the fact that it did not pass through adequate tests in order to be approved. Based on the effective use of surgical mesh products in the treatment of hernia in the 1950s, the production of vaginal mesh products come to birth.

Used by many physicians in earlier times, surgical mesh operations were done to correct internal disorders. It was in 1970 that its use in the treatment of Pelvic Organ Prolapse is recognized by many gynecologists. Surgical mesh specially designed as vaginal implant does not exist yet during that time, so surgeons would just cut out the mesh fit for their patients anatomy each time they do the procedure. The production of vaginal mesh was then made possible by manufacturers after growing demands of these products arise, and kits which contain instruments to aid in the implantation of the mesh are also made available in kits and distributed to the market. However, it was not until 1996 that vaginal mesh products were first acknowledged by the FDA.

The system used in the approval of vaginal mesh products to be made available in the market is inadequate since it did not measure the products efficacy and safety; it only ensured its equivalence to products existing in the market that had previously gained approval. The FDA announced in 2008 that complications of vaginal mesh products are mild and rare, but they withdrew their statement. In 2010, the FDA encouraged the help of all health care individuals to participate in the investigation conducted by the agency to have a better understanding of the complications that result from the use of vaginal mesh; and they also made further warnings on its safety and efficacy.

A tenth of those who went through vaginal mesh procedures are most likely to develop complications after a year since date of surgery, based on the FDAs rough calculations; these patients are more prone to further complications since corrective procedures are not usually successful. Frequent concerns of recipients are mesh erosion, bleeding, infections, pain, dyspareunia, pelvic organ perforations, and recurrence of prolapse.Removal of the mesh is needed, especially with these deadly complications.A lot of tissues can be removed through this procedure, making it dangerous and painful. These unpleasant circumstances make it possible for a recipient to file a vaginal mesh lawsuit against makers of these products who were negligent in providing safety warnings.